The European Commission is putting forward a Recommendation to support Member States in their efforts to prevent cancer through vaccination. Notably, it focuses on boosting the uptake of two key vaccinations that can prevent viral infections that may lead to cancer: against Human papillomaviruses (HPV) and Hepatitis B virus (HBV), as well as improving the monitoring of coverage rates.
The Recommendation is part of Europe’s Beating Cancer Plan, a key pillar of the European Health Union. It is estimated that about 40% of cancer cases in the EU are preventable. However, according to a new report published yesterday, only around 5% of total health spending was dedicated to prevention in the EU Member States in 2021.
Project PERCH is actively aligning with these objectives. PERCH focuses on establishing a common European data collection system to monitor population coverage and process indicators. The project also emphasizes multi-stakeholder engagement, providing national toolboxes for education, media campaigns, and support to healthcare professionals to combat vaccine hesitancy. The Governmental Advisory Board ensures sustainability by offering policy guidance and contributing to integration and sustainability plans.
You can read the full press release from the European Commission HERE
